Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma

Chromosomal rearrangements involving the c-ros oncogene 1 (ROS1) gene define a subset of non-small cell lung cancers highly sensitive to small-molecule tyrosine kinase inhibitors. However, little is known about the impact of different fusion partners on tyrosine kinase inhibitor efficacy. We herein...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Maurício Fernando Silva Almeida, Gadotti, Luiza Lara, Sacardo, Karina Perez, Lopes, Carlos Diego Holanda, Saddi, Rodrigo, Alessi, João Victor Machado, de Macedo, Mariana Petaccia, do Nascimento, Ellen Caroline Toledo, Testagrossa, Leonardo de Abreu, Katz, Artur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127844/
https://www.ncbi.nlm.nih.gov/pubmed/35619747
http://dx.doi.org/10.1177/2050313X221100407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127844/
https://www.ncbi.nlm.nih.gov/pubmed/35619747
http://dx.doi.org/10.1177/2050313X221100407

Ejemplares similares